Literature DB >> 32019669

Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020.

Julien Riou1, Christian L Althaus1.   

Abstract

Since December 2019, China has been experiencing a large outbreak of a novel coronavirus (2019-nCoV) which can cause respiratory disease and severe pneumonia. We estimated the basic reproduction number R0 of 2019-nCoV to be around 2.2 (90% high density interval: 1.4-3.8), indicating the potential for sustained human-to-human transmission. Transmission characteristics appear to be of similar magnitude to severe acute respiratory syndrome-related coronavirus (SARS-CoV) and pandemic influenza, indicating a risk of global spread.

Entities:  

Keywords:  2019-nCoV; Wuhan; coronavirus; emerging infectious disease; mathematical modelling

Mesh:

Year:  2020        PMID: 32019669      PMCID: PMC7001239          DOI: 10.2807/1560-7917.ES.2020.25.4.2000058

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


On 31 December 2019, the World Health Organization (WHO) was alerted about a cluster of pneumonia of unknown aetiology in the city of Wuhan, China [1,2]. Only a few days later, Chinese authorities identified and characterised a novel coronavirus (2019-nCoV) as the causative agent of the outbreak [3]. The outbreak appears to have started from a single or multiple zoonotic transmission events at a wet market in Wuhan where game animals and meat were sold [4] and has resulted in 5,997 confirmed cases in China and 68 confirmed cases in several other countries by 29 January 2020 [5]. Based on the number of exported cases identified in other countries, the actual size of the epidemic in Wuhan has been estimated to be much larger [6]. At this early stage of the outbreak, it is important to gain understanding of the transmission pattern and the potential for sustained human-to-human transmission of 2019-nCoV. Information on the transmission characteristics will help coordinate current screening and containment strategies, support decision making on whether the outbreak constitutes a public health emergency of international concern (PHEIC), and is key for anticipating the risk of pandemic spread of 2019-nCoV. In order to better understand the early transmission pattern of 2019-nCoV, we performed stochastic simulations of early outbreak trajectories that are consistent with the epidemiological findings to date.

Epidemic parameters

Two key properties will determine further spread of 2019-nCoV. Firstly, the basic reproduction number R describes the average number of secondary cases generated by an infectious index case in a fully susceptible population, as was the case during the early phase of the outbreak. If R is above the critical threshold of 1, continuous human-to-human transmission with sustained transmission chains will occur. Secondly, the individual variation in the number of secondary cases provides further information about the expected outbreak dynamics and the potential for superspreading events [7-9]. If the dispersion of the number of secondary cases is high, a small number of cases may be responsible for a disproportionate number of secondary cases, while a large number of cases will not transmit the pathogen at all. While superspreading always remain a rare event, it can result in a large and explosive transmission event and have a lot of impact on the course of an epidemic. Conversely, low dispersion would lead to a steadier growth of the epidemic, with more homogeneity in the number of secondary cases per index case. This has important implications for control efforts.

Simulating early outbreak trajectories

In a first step, we initialised simulations with one index case. For each primary case, we generated secondary cases according to a negative-binomial offspring distribution with mean R and dispersion k [7,8]. The dispersion parameter k quantifies the variability in the number of secondary cases, and can be interpreted as a measure of the impact of superspreading events (the lower the value of k, the higher the impact of superspreading). The generation time interval D was assumed to be gamma-distributed with a shape parameter of 2, and a mean that varied between 7 and 14 days. We explored a wide range of parameter combinations (Table) and ran 1,000 stochastic simulations for each individual combination. This corresponds to a total of 3.52 million one-index-case simulations that were run on UBELIX (http://www.id.unibe.ch/hpc), the high performance computing cluster at the University of Bern, Switzerland.
Table

Parameter ranges for stochastic simulations of outbreak trajectories, 2019 novel coronavirus outbreak, China, 2019–2020

ParameterDescriptionRangeNumber of values explored within the range
R0 Basic reproduction number0.8–5.022 (equidistant)
k Dispersion parameter0.011020 (equidistant on log10 scale)
D Generation time interval (days)9–11,13,16–198 (equidistant)
n Initial number of index cases1–506 (equidistant)
T Date of zoonotic transmission20 Nov–4 Dec 2019Randomised for each index case
In a second step, we accounted for the uncertainty regarding the number of index cases n and the date T of the initial zoonotic animal-to-human transmissions at the wet market in Wuhan. An epidemic with several index cases can be considered as the aggregation of several independent epidemics with one index case each. We sampled (with replacement) n of the one-index-case epidemics, sampled a date of onset for each index case and aggregated the epidemic curves together. The sampling of the date of onset was done uniformly from a 2-week interval around 27 November 2019, in coherence with early phylogenetic analyses of 11 2019-nCoV genomes [10]. This step was repeated 100 times for each combination of R (22 points), k (20 points), D (8 points) and n (6 points) for a total of 2,112,000 full epidemics simulated that included the uncertainty on D, n and T. Finally, we calculated the proportion of stochastic simulations that reached a total number of infected cases within the interval between 1,000 and 9,700 by 18 January 2020, as estimated by Imai et al. [6]. In a process related to approximate Bayesian computation (ABC), the parameter value combinations that led to simulations within that interval were treated as approximations to the posterior distributions of the parameters with uniform prior distributions. Model simulations and analyses were performed in the R software for statistical computing [11]. Code files are available on https://github.com/jriou/wcov.

Transmission characteristics of the 2019 novel coronavirus

In order to reach between 1,000 and 9,700 infected cases by 18 January 2020, the early human-to-human transmission of 2019-nCoV was characterised by values of R around 2.2 (median value, with 90% high density interval: 1.4–3.8) (Figure 1). The observed data at this point are compatible with a large range of values for the dispersion parameter k (median: 0.54, 90% high density interval: 0.014–6.95). However, our simulations suggest that very low values of k are less likely. These estimates incorporate the uncertainty about the total epidemic size on 18 January 2020 and about the date and scale of the initial zoonotic event (Figure 2).
Figure 1

Values of R and k most compatible with the estimated size of the 2019 novel coronavirus epidemic in China, on 18 January 2020

Figure 2

Illustration of the simulation strategy, 2019 novel coronavirus outbreak, China, 2019–2020

Values of R and k most compatible with the estimated size of the 2019 novel coronavirus epidemic in China, on 18 January 2020 The basic reproduction number R quantifies human-to-human transmission. The dispersion parameter k quantifies the risk of a superspreading event (lower values of k are linked to a higher probability of superspreading). Note that the probability density of k implies a log10 transformation. Illustration of the simulation strategy, 2019 novel coronavirus outbreak, China, 2019–2020 The lines represent the cumulative incidence of 480 simulations with R and k = 1.13. The other parameters are left to vary according to the Table. Among these simulated epidemics, 54.3% led to a cumulative incidence between 1,000 and 9,700 on 18 January 2020 (in red).

Comparison with past emergences of respiratory viruses

Comparison with other emerging coronaviruses in the past allows to put into perspective the available information regarding the transmission patterns of 2019-nCoV. Figure 3 shows the combinations of R and k that are most likely at this stage of the epidemic. Our estimates of R and k are more similar to previous estimates focusing on early human-to-human transmission of SARS-CoV in Beijing and Singapore [7] than of Middle East respiratory syndrome-related coronavirus (MERS-CoV) [9]. The spread of MERS-CoV was characterised by small clusters of transmission following repeated instances of animal-to-human transmission events, mainly driven by the occurrence of superspreading events in hospital settings. MERS-CoV could however not sustain human-to-human transmission beyond a few generations [12]. Conversely, the international spread of SARS-CoV lasted for 9 months and was driven by sustained human-to-human transmission, with occasional superspreading events. It led to more than 8,000 cases around the world and required extensive efforts by public health authorities to be contained [13]. Our assessment of the early transmission of 2019-nCoV suggests that 2019-nCoV might follow a similar path.
Figure 3

Proportion of simulated epidemics that lead to a cumulative incidence between 1,000 and 9,700 of the 2019 novel coronavirus outbreak, China, on 18 January 2020

Proportion of simulated epidemics that lead to a cumulative incidence between 1,000 and 9,700 of the 2019 novel coronavirus outbreak, China, on 18 January 2020 MERS: Middle East respiratory syndrome-related coronavirus; SARS: severe acute respiratory syndrome-related coronavirus. This can be interpreted as the combinations of R and k values most compatible with the estimation of epidemic size before quarantine measures were put in place. As a comparison, we show the estimates of R and k for the early human-to-human transmission of SARS-CoV in Singapore and Beijing and of 1918 pandemic influenza [7,9,14]. Our estimates for 2019-nCoV are also compatible with those of 1918 pandemic influenza, for which k was estimated [14]. Human-to-human transmission of influenza viruses is characterised by R values between 1.5 and 2 and a larger value of k, implying a more steady transmission without superspreading. The emergence of new strains of influenza, for which human populations carried little to no immunity contrary to seasonal influenza, led to pandemics with different severity such as the ones in1918, 1957 1968 and 2009. It is notable that coronaviruses differ from influenza viruses in many aspects, and evidence for the 2019-nCoV with respect to case fatality rate, transmissibility from asymptomatic individuals and speed of transmission is still limited. Without speculating about possible consequences, the values of R and k found here during the early stage of 2019-nCoV emergence and the lack of immunity to 2019-nCoV in the human population leave open the possibility for pandemic circulation of this new virus.

Strengths and limitations

The scarcity of available data, especially on case counts by date of disease onset as well as contact tracing, greatly limits the precision of our estimates and does not yet allow for reliable forecasts of epidemic spread. Case counts provided by local authorities in the early stage of an emerging epidemic are notoriously unreliable as reporting rates are unstable and vary with time. This is due to many factors such as the initial lack of proper diagnosis tools, the focus on the more severe cases or the overcrowding of hospitals. We avoided this surveillance bias by relying on an indirect estimate of epidemic size on 18 January, based on cases identified in foreign countries before quarantine measures were implemented on 23 January. This estimated range of epidemic size relies itself on several assumptions, including that all infected individuals who travelled from Wuhan to other countries have been detected [6]. This caveat may lead to an underestimation of transmissibility, especially considering the recent reports about asymptomatic cases [4]. Conversely, our results do not depend on any assumption about the existence of asymptomatic transmission, and only reflect the possible combinations of transmission events that lead to the situation on 18 January. Our analysis, while limited because of the scarcity of data, has two important strengths. Firstly, it is based on the simulation of a wide range of possibilities regarding epidemic parameters and allows for the full propagation on the final estimates of the many remaining uncertainties regarding 2019-nCoV and the situation in Wuhan: on the actual size of the epidemic, on the size of the initial zoonotic event at the wet market, on the date(s) of the initial animal-to-human transmission event(s) and on the generation time interval. As it accounts for all these uncertainties, our analysis provides a summary of the current state of knowledge about the human-to-human transmissibility of 2019-nCoV. Secondly, its focus on the possibility of superspreading events by using negative-binomial offspring distributions appears relevant in the context of emerging coronaviruses [7,8]. While our estimate of k remains imprecise, the simulations suggest that very low values of k < 0.1 are less likely than higher values < 0.1 that correspond to a more homogeneous transmission pattern. However, values of k in the range of 0.1–0.2 are still compatible with a small risk of occurrence of large superspreading events, especially impactful in hospital settings [15,16].

Conclusions

Our analysis suggests that the early pattern of human-to-human transmission of 2019-nCoV is reminiscent of SARS-CoV emergence in 2002. International collaboration and coordination will be crucial in order to contain the spread of 2019-nCoV. At this stage, particular attention should be given to the prevention of possible rare but explosive superspreading events, while the establishment of sustained transmission chains from single cases cannot be ruled out. The previous experience with SARS-CoV has shown that established practices of infection control, such as early detection and isolation, contact tracing and the use of personal protective equipment, can stop such an epidemic. Given the existing uncertainty around the case fatality rate and transmission, our findings confirm the importance of screening, surveillance and control efforts, particularly at airports and other transportation hubs, in order to prevent further international spread of 2019-nCoV.
  10 in total

1.  Effectiveness of control measures during the SARS epidemic in Beijing: a comparison of the Rt curve and the epidemic curve.

Authors:  B J Cowling; L M Ho; G M Leung
Journal:  Epidemiol Infect       Date:  2007-06-14       Impact factor: 2.451

2.  Influenza transmission in households during the 1918 pandemic.

Authors:  Christophe Fraser; Derek A T Cummings; Don Klinkenberg; Donald S Burke; Neil M Ferguson
Journal:  Am J Epidemiol       Date:  2011-07-11       Impact factor: 4.897

3.  The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission.

Authors:  A J Kucharski; C L Althaus
Journal:  Euro Surveill       Date:  2015-06-25

4.  Hospital outbreak of Middle East respiratory syndrome coronavirus.

Authors:  Abdullah Assiri; Allison McGeer; Trish M Perl; Connie S Price; Abdullah A Al Rabeeah; Derek A T Cummings; Zaki N Alabdullatif; Maher Assad; Abdulmohsen Almulhim; Hatem Makhdoom; Hossam Madani; Rafat Alhakeem; Jaffar A Al-Tawfiq; Matthew Cotten; Simon J Watson; Paul Kellam; Alimuddin I Zumla; Ziad A Memish
Journal:  N Engl J Med       Date:  2013-06-19       Impact factor: 91.245

5.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

6.  Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk.

Authors:  Romulus Breban; Julien Riou; Arnaud Fontanet
Journal:  Lancet       Date:  2013-07-05       Impact factor: 79.321

7.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

8.  Ebola superspreading.

Authors:  Christian L Althaus
Journal:  Lancet Infect Dis       Date:  2015-04-19       Impact factor: 25.071

9.  Superspreading and the effect of individual variation on disease emergence.

Authors:  J O Lloyd-Smith; S J Schreiber; P E Kopp; W M Getz
Journal:  Nature       Date:  2005-11-17       Impact factor: 49.962

10.  Middle East Respiratory Syndrome Coronavirus Superspreading Event Involving 81 Persons, Korea 2015.

Authors:  Myoung-don Oh; Pyoeng Gyun Choe; Hong Sang Oh; Wan Beom Park; Sang-Min Lee; Jinkyeong Park; Sang Kook Lee; Jeong-Sup Song; Nam Joong Kim
Journal:  J Korean Med Sci       Date:  2015-10-16       Impact factor: 2.153

  10 in total
  384 in total

1.  CT imaging features of COVID-19 pneumonia: initial experience from Turkey.

Authors:  Akın Çinkooğlu; Cenk Hepdurgun; Selen Bayraktaroğlu; Naim Ceylan; Recep Savaş
Journal:  Diagn Interv Radiol       Date:  2020-07       Impact factor: 2.630

2.  Early in the Epidemic: Impact of Preprints on Global Discourse of 2019-nCoV Transmissibility.

Authors:  Maimuna S Majumder; Kenneth D Mandl
Journal:  SSRN       Date:  2020-02-12

3.  COVID-19 managed with early non-invasive ventilation and a bundle pharmacotherapy: A case report.

Authors:  Mian Peng; Di Ren; Xue-Yan Liu; Jin-Xiu Li; Rong-Lin Chen; Bao-Jun Yu; Yong-Feng Liu; Xi Meng; Yan-Si Lyu
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

4.  Effectiveness of interventions targeting air travellers for delaying local outbreaks of SARS-CoV-2.

Authors:  Samuel Clifford; Carl A B Pearson; Petra Klepac; Kevin Van Zandvoort; Billy J Quilty; Rosalind M Eggo; Stefan Flasche
Journal:  J Travel Med       Date:  2020-08-20       Impact factor: 8.490

Review 5.  The Role of Smoking and Nicotine in the Transmission and Pathogenesis of COVID-19.

Authors:  Ali Ehsan Sifat; Saeideh Nozohouri; Heidi Villalba; Bhuvaneshwar Vaidya; Thomas J Abbruscato
Journal:  J Pharmacol Exp Ther       Date:  2020-10-08       Impact factor: 4.030

Review 6.  The reproductive number of COVID-19 is higher compared to SARS coronavirus.

Authors:  Ying Liu; Albert A Gayle; Annelies Wilder-Smith; Joacim Rocklöv
Journal:  J Travel Med       Date:  2020-03-13       Impact factor: 8.490

Review 7.  The COVID-19 pandemic and the potential treatment of the novel coronavirus SARS-CoV-2.

Authors:  Shilei Wang; Jinlei Ye; Zhichao Kang; Hongmei Peng; Vienna Mackey; Lichun Sun
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

8.  Global convergence of COVID-19 basic reproduction number and estimation from early-time SIR dynamics.

Authors:  Gabriel G Katul; Assaad Mrad; Sara Bonetti; Gabriele Manoli; Anthony J Parolari
Journal:  PLoS One       Date:  2020-09-24       Impact factor: 3.240

9.  The effectiveness of social bubbles as part of a Covid-19 lockdown exit strategy, a modelling study.

Authors:  Trystan Leng; Connor White; Joe Hilton; Adam Kucharski; Lorenzo Pellis; Helena Stage; Nicholas G Davies; Matt J Keeling; Stefan Flasche
Journal:  Wellcome Open Res       Date:  2021-03-29

Review 10.  COVID-19: breaking down a global health crisis.

Authors:  Saad I Mallah; Omar K Ghorab; Sabrina Al-Salmi; Omar S Abdellatif; Tharmegan Tharmaratnam; Mina Amin Iskandar; Jessica Atef Nassef Sefen; Pardeep Sidhu; Bassam Atallah; Rania El-Lababidi; Manaf Al-Qahtani
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-05-18       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.